IHVN Tasks Media to Boost PrEP Awareness

IHVN Tasks Media to Boost PrEP Awareness

The Institute of Human Virology in Nigeria called on journalists on Thursday, 8 October 2026, to dismantle pervasive public stigma and spur the uptake of pre-exposure prophylaxis against HIV across the federation. Health authorities gathered editors in Lagos alongside delegates from the National Agency for the Control of AIDS to arrest an alarming trend of new viral infections among young adults and vulnerable key populations. Scientific breakthroughs mean very little in clinical isolation. Public ignorance and moral panic continue to throttle the distribution of preventive antiretroviral therapies even though donor-backed clinics supply them free of charge.

Medical specialists told reporters that daily oral prophylaxis slashes the transmission risk of human immunodeficiency virus by more than ninety per cent when individuals swallow the pills as prescribed. Newsrooms continue to treat HIV prevention as a morbid clinical subject rather than a normal, life-saving lifestyle routine. Fear silences those who need protection most. Sufferers and high-risk groups dread social shaming from hospital workers and neighbours far more than they fear the biological pathogen itself, choosing silent exposure over the indignity of public finger-pointing in neighbourhood dispensaries.

Federal agencies rely on external charity partners like the Global Fund and the American PEPFAR programme to finance testing kits, logistics corridors, and bulk drug consignments. Nigeria now risks missing the global target to eradicate the epidemic by 2030 unless local authorities persuade at-risk citizens to seek early preventive treatment before clinical exposure occurs. Donors will not underwrite basic carelessness forever. Public health officers must convince regional media practitioners to report pharmaceutical research with accurate nuance instead of recycling sensational myths that equate chemical prevention with promiscuous social decay.

Clinic directors report that thousands of eligible citizens skip free hospital collections because primary health centres sit in crowded municipal wards where privacy does not exist. Long-acting injectable alternatives now expand prevention options across Western capitals, but bureaucratic bottlenecks and fiscal paralysis keep domestic health services tethered to cumbersome daily oral regimens. Paper declarations cannot modernise community dispensaries. Bureaucrats in Abuja routinely host plush hotel seminars on health communication while rural community health centres run out of basic diagnostic strips and trained auxiliary nurses.

Editors must replace moral lectures with plain scientific facts to educate a sceptical public about chemical barrier options before casual infections overwhelm strained public hospitals. Nigerian families struggle with prohibitive transport fares and expensive private healthcare bills that make preventive visits to regional clinics an unaffordable daily luxury. Empty rhetoric cures no viral outbreaks. The federal health ministry must decentralise confidential drug distribution outside traditional hospital gates, protect patient privacy from prying eyes, and fund sustainable local outreach programmes before another preventable health disaster sweeps through the nation’s youth.